Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SGottliebFDA
Tracking Since: October 20, 2017
THREAD: 1/2 In a forthcoming #FDA study, which we’ll be releasing shortly, we found that for a large set of high-volume generic drugs, manufacturers’ prices in the U.S. in 2017 were significantly less than the foreign prices charged in eight of nine foreign countries we studied
More and more I’m hearing from parents of kids who are addicted to nicotine and e-cigs; telling me how easy it is for teens to buy these e-cigs, how the e-cig images are all over social media, how their kids tell them so many of their peer group in high school are using them
We are delighted to welcome Stacy Amin as the #FDA’s new chief counsel. She brings a wide breadth of experience in healthcare, law and policy; an unflinching devotion to the public health; and a deep understand of, and appreciation for, the special mission of our agency.
FDA’s compounding program is a priority. As the revised draft MOU shows, we are balancing the need to preserve access to appropriately compounded drugs for patients who need them with the need to protect patients from poor quality compounded drugs that could cause harm. https://t.co/TBHB6F68t7